These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

305 related articles for article (PubMed ID: 21380595)

  • 21. B lymphocyte-induced maturation protein 1 (BLIMP-1) attenuates autoimmune diabetes in NOD mice by suppressing Th1 and Th17 cells.
    Lin MH; Chou FC; Yeh LT; Fu SH; Chiou HY; Lin KI; Chang DM; Sytwu HK
    Diabetologia; 2013 Jan; 56(1):136-46. PubMed ID: 23052053
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Surge in regulatory T cells does not prevent onset of hyperglycemia in NOD mice: immune profiles do not correlate with disease severity.
    Kaminitz A; Mizrahi K; Askenasy N
    Autoimmunity; 2014 Mar; 47(2):105-12. PubMed ID: 24328490
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Increased CD4
    Ma YH; Zhang J; Chen X; Xie YF; Pang YH; Liu XJ
    World J Gastroenterol; 2016 Nov; 22(42):9356-9367. PubMed ID: 27895423
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Upregulating CD4+CD25+FOXP3+ regulatory T cells in pancreatic lymph nodes in diabetic NOD mice by adjuvant immunotherapy.
    Tian B; Hao J; Zhang Y; Tian L; Yi H; O'Brien TD; Sutherland DE; Hering BJ; Guo Z
    Transplantation; 2009 Jan; 87(2):198-206. PubMed ID: 19155973
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Temporal relationship between immune cell influx and the expression of inducible nitric oxide synthase, interleukin-4 and interferon-gamma in pancreatic islets of NOD mice following adoptive transfer of diabetic spleen cells.
    Reddy S; Karanam M; Krissansen G; Nitschke K; Neve J; Poole CA; Ross JM
    Histochem J; 2000 Apr; 32(4):195-206. PubMed ID: 10872884
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Smad4 in T cells plays a protective role in the development of autoimmune Sjögren's syndrome in the nonobese diabetic mouse.
    Kim D; Kim JY; Jun HS
    Oncotarget; 2016 Dec; 7(49):80298-80312. PubMed ID: 27880731
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Deoxyhypusine synthase promotes differentiation and proliferation of T helper type 1 (Th1) cells in autoimmune diabetes.
    Colvin SC; Maier B; Morris DL; Tersey SA; Mirmira RG
    J Biol Chem; 2013 Dec; 288(51):36226-35. PubMed ID: 24196968
    [TBL] [Abstract][Full Text] [Related]  

  • 28. IL-10 Deficiency Accelerates Type 1 Diabetes Development
    Huang J; Tan Q; Tai N; Pearson JA; Li Y; Chao C; Zhang L; Peng J; Xing Y; Zhang L; Hu Y; Zhou Z; Wong FS; Wen L
    Front Immunol; 2021; 12():702955. PubMed ID: 34394099
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Activation of aryl hydrocarbon receptor by TCDD prevents diabetes in NOD mice and increases Foxp3+ T cells in pancreatic lymph nodes.
    Kerkvliet NI; Steppan LB; Vorachek W; Oda S; Farrer D; Wong CP; Pham D; Mourich DV
    Immunotherapy; 2009 Jul; 1(4):539-47. PubMed ID: 20174617
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Innate immunity and intestinal microbiota in the development of Type 1 diabetes.
    Wen L; Ley RE; Volchkov PY; Stranges PB; Avanesyan L; Stonebraker AC; Hu C; Wong FS; Szot GL; Bluestone JA; Gordon JI; Chervonsky AV
    Nature; 2008 Oct; 455(7216):1109-13. PubMed ID: 18806780
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Interleukin-1β produced in response to islet autoantigen presentation differentiates T-helper 17 cells at the expense of regulatory T-cells: Implications for the timing of tolerizing immunotherapy.
    Bertin-Maghit S; Pang D; O'Sullivan B; Best S; Duggan E; Paul S; Thomas H; Kay TW; Harrison LC; Steptoe R; Thomas R
    Diabetes; 2011 Jan; 60(1):248-57. PubMed ID: 20980463
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prolonged antibiotic treatment induces a diabetogenic intestinal microbiome that accelerates diabetes in NOD mice.
    Brown K; Godovannyi A; Ma C; Zhang Y; Ahmadi-Vand Z; Dai C; Gorzelak MA; Chan Y; Chan JM; Lochner A; Dutz JP; Vallance BA; Gibson DL
    ISME J; 2016 Feb; 10(2):321-32. PubMed ID: 26274050
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Th1-Like ICOS+ Foxp3+ Treg Cells Preferentially Express CXCR3 and Home to β-Islets during Pre-Diabetes in BDC2.5 NOD Mice.
    Kornete M; Mason ES; Girouard J; Lafferty EI; Qureshi S; Piccirillo CA
    PLoS One; 2015; 10(5):e0126311. PubMed ID: 25946021
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immunoregulatory Cordyceps sinensis increases regulatory T cells to Th17 cell ratio and delays diabetes in NOD mice.
    Shi B; Wang Z; Jin H; Chen YW; Wang Q; Qian Y
    Int Immunopharmacol; 2009 May; 9(5):582-6. PubMed ID: 19557879
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Modulation of Gut Microbiota by Low Methoxyl Pectin Attenuates Type 1 Diabetes in Non-obese Diabetic Mice.
    Wu C; Pan LL; Niu W; Fang X; Liang W; Li J; Li H; Pan X; Chen W; Zhang H; Lakey JRT; Agerberth B; de Vos P; Sun J
    Front Immunol; 2019; 10():1733. PubMed ID: 31417546
    [TBL] [Abstract][Full Text] [Related]  

  • 36. All-trans retinoic acid inhibits type 1 diabetes by T regulatory (Treg)-dependent suppression of interferon-gamma-producing T-cells without affecting Th17 cells.
    Van YH; Lee WH; Ortiz S; Lee MH; Qin HJ; Liu CP
    Diabetes; 2009 Jan; 58(1):146-55. PubMed ID: 18984738
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prevention of murine autoimmune diabetes by CCL22-mediated Treg recruitment to the pancreatic islets.
    Montane J; Bischoff L; Soukhatcheva G; Dai DL; Hardenberg G; Levings MK; Orban PC; Kieffer TJ; Tan R; Verchere CB
    J Clin Invest; 2011 Aug; 121(8):3024-8. PubMed ID: 21737880
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Reduced IL-2 expression in NOD mice leads to a temporal increase in CD62Llo FoxP3+ CD4+ T cells with limited suppressor activity.
    Goudy KS; Johnson MC; Garland A; Li C; Samulski RJ; Wang B; Tisch R
    Eur J Immunol; 2011 May; 41(5):1480-1490. PubMed ID: 21469091
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Extracellular high-mobility group box 1 acts as an innate immune mediator to enhance autoimmune progression and diabetes onset in NOD mice.
    Han J; Zhong J; Wei W; Wang Y; Huang Y; Yang P; Purohit S; Dong Z; Wang MH; She JX; Gong F; Stern DM; Wang CY
    Diabetes; 2008 Aug; 57(8):2118-27. PubMed ID: 18477810
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cyclophosphamide-induced type-1 diabetes in the NOD mouse is associated with a reduction of CD4+CD25+Foxp3+ regulatory T cells.
    Brode S; Raine T; Zaccone P; Cooke A
    J Immunol; 2006 Nov; 177(10):6603-12. PubMed ID: 17082572
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.